Printer Friendly
The Free Library
14,558,173 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cancer care.


Cancer Care: Insert Therapeutics, a majority-owned subsidiary majority-owned subsidiary

A firm in which more than 50% of outstanding voting stock is owned by the parent company.
 of the publicly traded nanotechnology company, Arrowhead arrowhead, any plant of the genus Sagittaria, widely distributed marsh or aquatic herbs of the primitive family Alismataceae (water-plantain family). The name derives from the arrowhead-shaped leaves of many species.  Research Corp., signed an agreement with R & D Biopharmaceuticals to acquire an exclusive worldwide license to epothilone anticancer drugs Anticancer Drugs Definition

Anticancer, or antineoplastic, drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
. Epothilones are potent cancer fighters, but they have encountered clinical difficulties because of toxic side effects Side effects

Effects of a proposed project on other parts of the firm.
 they cause in patients. Insert will apply its proprietary Cyclosert transport system to the epothilones.
COPYRIGHT 2007 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Pasadena; Insert Therapeutics signs contract with R & D Biopharmaceuticals
Publication:Los Angeles Business Journal
Article Type:Brief article
Geographic Code:1U9CA
Date:Mar 12, 2007
Words:64
Previous Article:Contract News.(Pasadena)
Next Article:Ground breaking.(Burbank)(Brief article)
Topics:



Related Articles
Alkermes and Boehringer Mannheim sign development agreement.
Alkermes and Boehringer Mannheim sign development agreement.
Geron and Pharmacia & Upjohn announce signing of agreement to develop new class of anticancer drugs.
ImClone Systems and American Home Products Extend Collaboration to Develop Vaccine for Gonorrhea.
Insert Therapeutics Inc. Reports In Vivo Performance of Cyclosert-Camptothecin Anti-Cancer Formulation.
LORUS SIGNS VIRULIZIN SUPPLY PACT WITH BIOVECTRA.
Cancer treatment.(from Insert Therapeutics Inc.)(Brief Article)
Arrowhead Subsidiary, Insert Therapeutics, Featured in Pasadena Star-News.
Arrowhead Subsidiary, Insert Therapeutics, Signs Collaboration and Option Agreement for Potent Anti-Cancer Compound, Tubulysin.
Biotech/biomed companies: ranked by total employment.(HEALTH CARE)(Company rankings)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles